August 4, 1999 Dockets Management Branch, HFA-305 Food and Drug -4dministration 5630 Fishers Lane Room 1061 - Generally recognized as safe and effective - Document - PDFSEARCH.IO

First Page	Meta Content
	August 4, 1999 Dockets Management Branch, HFA-305 Food and Drug -4dministration 5630 Fishers Lane Room 1061 Add to Reading List Document Date: 2007-11-07 12:46:40 Open Document File Size: 253,64 KB Share Result on Facebook City Rockville / North Mt / / Company Knoll Pharmaceutical Company / / / Event FDA Phase / / IndustryTerm sodium products / levothyroxine applications / / Organization US Federal Reserve / FDA / Center for Drug Evaluation and Research / / Person Roy V. Castle / Jr. / Gary L. Veron / Nancy L. But / Steven J. Goldberg / Melvin K. Spigelman / / / Position Vice President of Research and Development Nancy L. / Chief Regulatory Counsel / Vice President / Quality Assurance Of Counsel / / Product levothyroxine sodium / Synthroid / Citizen Petition / Knoll / / ProvinceOrState New Jersey / Maryland / / Technology Pharmacokinetics / / SocialTag Norfloxacin Food and Drug Administration Freedom of Information Act Freedom of information legislation Generally recognized as safe and effective Medicinal chemistry Piperazines Pharmaceutical sciences Clinical research

August 4, 1999 Dockets Management Branch, HFA-305 Food and Drug -4dministration 5630 Fishers Lane Room 1061Add to Reading List